Author: Fitton, J. Helen; Park, Ah Young; Karpiniec, Samuel S.; Stringer, Damien N.
Title: Fucoidan and Lung Function: Value in Viral Infection Cord-id: 9px6lzj9 Document date: 2020_12_24
ID: 9px6lzj9
Snippet: Compromised lung function is a feature of both infection driven and non-infective pathologies. Viral infections—including the current pandemic strain SARS-CoV-2—that affect lung function can cause both acute and long-term chronic damage. SARS-CoV-2 infection suppresses innate immunity and promotes an inflammatory response. Targeting these aspects of SARS-CoV-2 is important as the pandemic affects greater proportions of the population. In clinical and animal studies, fucoidans have been shown
Document: Compromised lung function is a feature of both infection driven and non-infective pathologies. Viral infections—including the current pandemic strain SARS-CoV-2—that affect lung function can cause both acute and long-term chronic damage. SARS-CoV-2 infection suppresses innate immunity and promotes an inflammatory response. Targeting these aspects of SARS-CoV-2 is important as the pandemic affects greater proportions of the population. In clinical and animal studies, fucoidans have been shown to increase innate immunity and decrease inflammation. In addition, dietary fucoidan has been shown to attenuate pulmonary damage in a model of acute viral infection. Direct inhibition of SARS-CoV-2 in vitro has been described, but is not universal. This short review summarizes the current research on fucoidan with regard to viral lung infections and lung damage.
Search related documents:
Co phrase search for related documents- acute mouse lung injury and lung damage model: 1, 2
- additional study and long covid: 1, 2, 3, 4
- long covid and lung damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- lps induce and lung damage: 1, 2
Co phrase search for related documents, hyperlinks ordered by date